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Abstract
This is a prospective observational cohort study aiming to include 4000 patients with stages I to III
colon cancer treated at 35 specialist institutions in Japan, South Korea, Germany, Russia, Lithuania
and Taiwan. The anatomical distribution of lymph nodes and feeding arteries are investigated using
surgical specimens according to pre-specified categorizing methods using intraoperative anatom-
ical markings. Primary analyses are performed to identify the general principles of metastatic
lymph node distribution in terms of its relation to the location of the primary tumor and feeding
arteries. Secondary analyses will be used to estimate prognostic outcomes according to bowel
resection length and central radicality and will be used to evaluate the quality of resected surgical
specimens. Through in-depth lymph node mapping, standardized criteria for the definite area
of ‘regional’ lymph node resection in routine surgical procedures can be identified, which is
expected to contribute to international standardization in colon cancer surgery (ClinicalTrials.gov
NCT02938481).
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Figure 1. Lymph node classification in colon cancer. According to the Japanese Classification of Colorectal Carcinoma (2nd English edition), lymph nodes were
classified into pericolic, intermediate and main lymph nodes. Note that different anatomical landmarks are used to determine main lymph nodes depending on
the primary tumor location (i.e. main lymph nodes are those along the superior mesenteric artery/vein for tumors in the right-sided colon or those located along
the inferior mesenteric artery proximal to the origin of the left colic artery in the left-sided colon). (Reprinted with permission from “Japanese D3 Dissection” by
Hideki Ueno and Kenichi Sugihara in Surgical Treatment of Colorectal Cancer (ISBN 978-981-10-5142-5; Springer Nature Singapore Pte Ltd. 2018))
Introduction
Although standardization of surgical procedures is expected to
improve oncological long-term outcomes (1), there is a great deal
of international variation in colon cancer surgery, especially in terms
of the length of bowel resection and central radicality. For example,
studies have reported that the length of resected bowel specimens in
Japan is approximately half that of resected specimens from specialist
institutions in Western countries such as Germany (2).
In addition, from an international viewpoint, there are various
anatomical landmarks of central radicality that vary by country;
these include the middle of the colic arteries (3), the superior mesen-
teric vein/artery (4), and the extramesenteric lymph nodes over the
head of the pancreas and along the gastroepiploic arcade (1). The
resection margin of the bowel and central radicality are significantly
associated with patients’ oncologic outcomes after surgery. There
are a number of possible reasons for such noticeable international
differences in surgical procedures.
First, although the optimal extent of bowel resection in colon
cancer surgery is largely determined by how one defines regional
pericolic lymph nodes, which should be removed in routine practice
because of the risk of harboring metastatic disease in the pericolic
area, there are no standardized criteria for regional pericolic lymph
nodes. Second, central lymph node dissection, a surgical procedure
that characterizes both complete mesocolic excision (CME) and
Japanese D3 dissection, has recently attracted the attention of col-
orectal surgeons as a high-quality surgery to treat colon cancer; how-
ever, its surgical indication has not been confirmed. Third, although
ethnic differences in physique are widely recognized, whether there
are ethnic differences in the distribution of lymph nodes and feeding
arteries has not been studied. This information should be clarified to
estimate whether globally standardized surgical procedures for colon
cancer can be successfully achieved.
An international symposium ‘Standardization of Surgical Treat-
ment of Colon Cancer’ was organized by Prof. Sugihara with support
by Translational Research Center for Medical Innovation (TRI) in
Tokyo, Japan, in 2013. At this symposium, researchers from the USA,
Europe and Asia presented their surgical procedures and treatment
outcomes to discuss standardization of surgical procedures. As a
result, it was recognized that an international collaborative study
with a common study protocol was to be made in order to establish
scientific evidence for the optimal resection margin of the bowel and
anatomical landmarks of central radicality in colon cancer surgery.
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Figure 2. Schematic of the levels of central radicality in the T-REX study. Three categories of lymphadenectomy are provided for central radicality according to
pre-specified anatomical landmarks. Subclassifications are provided for level C in tumors located in the ileocolic and right colic artery area and for level B in
tumors located in the sigmoid artery area.
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Figure 3. Intraoperative markings and identification of feeding arteries in resected specimens. Intraoperative markings on the bowel at 5 cm intervals make 11
pericolic segments: i.e. primary tumor area; 0 < D ≤ 5 cm (proximal/distal sides); 5 < D ≤ 10 cm (proximal/distal sides); 10 < D ≤ 15 cm (proximal/distal sides);
15 < D ≤ 20 cm (proximal/distal sides) and 20 cm < D (proximal/distal sides). The location of feeding arteries and pericolic lymph nodes are classified according
to these segments.
Based on such clinical situations in the field of colon cancer, the
International Prospective Observational Cohort Study for Optimal
Bowel Resection Extent and Central Radicality for Colon Cancer
(T-REX study) was conducted by the Japanese Society for Cancer of
the Colon and Rectum (JSCCR). In this study, the actual distribution
of the metastatic nodes in the pericolic, intermediate, and main lymph
nodes (Fig. 1) and its association with the location of the primary
tumor and feeding artery will be elucidated. The primary purpose
of the study is to establish an international consensus on the extent
of bowel resection and appropriate central lymphadenectomy in
colon cancer surgery based on an in-depth analysis of lymph node
mapping.
Patients and methods
Study type and ethical issues
The T-REX study is an international, multicenter, prospective, obser-
vational, cohort study that collects clinical and pathological data
to assess the metastatic lymph node distribution and identify the
optimal length of bowel resection and central radicality for colon
cancer management.
This study was conducted in accordance with the Declaration
of Helsinki, as amended on October 22, 2008, by the 59th World
Medical Association General Assembly in Seoul (https://www.wma.
net/wp-content/uploads/2018/07/DoH-Oct2008.pdf).
The final study protocol, including the final version of the subject
information and consent forms, were approved in writing by the
Ethics Committee of the JSCCR and the Investigational Review
Board of each institution. Patients are included in the T-REX study
only after written informed consent has been obtained.
Sample size setting
One of the important investigations in the T-REX study is the sub-
population analysis, including the analysis of metastatic lymph node
distribution according to T stage, for which stages T1, T2, T3,
T4a and T4b, respectively, account for 17%, 13%, 56%, 8% and
6% in patients with colon cancer (5). The sample size calculation
depended on the number of patients that should be included in the
smallest population sub-set, i.e. the T4b population. On the basis
of the consensus of opinion among the investigators, the number
of patients included as the smallest population was determined to
be ∼200. Consequently, the target sample size of the T-REX study
is 4000, which allows for a margin of error of 1% in the T4b
population.
Patients included
Patients with colon cancer of preoperative stage I, II or III, who
received potentially curative surgery at participating institutions
(Table 1), are recruited between 30 May 2013, and 31 December
2018. The patient enrollment was initially started on 30 May 2013,
only in Japan and then started internationally on 22 January 2015.
The data of patients registered until 30 May2013, which include
only those of Japanese patients, will be analyzed together with
the international data. The inclusion criteria are as follows: (1)
histologically proven colon adenocarcinoma; (2) pathological stage I,
II or III; (3) potentially curative surgery; and (4) informed consent for
observational data collection. Based on the protocol, the following
patients are excluded from the study: (1) patients with Tis (mucosal
cancer), (2) patients with multiple colon cancers, and (3) patients
with preoperative adjuvant therapy.
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Figure 4. Patterns of feeding artery distribution. According to the Japanese Classification of Colorectal Carcinoma (2nd English edition), the pattern of feeding
artery distribution is classified into four based on the distance of the first and second feeding arteries from the primary tumor.
Parameters collected
All clinicopathological information is collected via the electronic
data capture system, eClinical Base (eCB®) administered by the TRI.
The data collected included patient characteristics (age, sex, height,
body weight and tumor location); surgery-related factors (year and
month of surgery, operation type, intraoperative marking method,
length of bowel resected, level of central radicality [Fig. 2], operation
time and estimated blood loss and morbidity and mortality); feeding
artery information (the location of the first and second feeding
arteries, distance from the primary tumor [Fig. 3] and pattern of
feeding artery distribution [Fig. 4]); pathological information (timing
of lymph node retrieval, depth of tumor invasion (pT), tumor grade,
residual tumor, circumferential margin involvement and lymph node
distribution status [Fig. 5]); and adjuvant chemotherapy information
(Table 2). Prognostic information (year and month of last follow-up,
prognostic outcome, year and month of recurrence and recurrence
site) will be collected at 4 years after the last patient registration
(January 2023). Photographs of resected surgical specimens are
collected, and their quality will be assessed by central review as
described below.
Intraoperative procedure (surgical process)
This study does not regulate the level of lymph node dissection
or the bowel resection length. Retrieved lymph nodes are grouped
as pericolic, intermediate or main lymph nodes (Fig. 1). This study
provides the original classification for the level of central radicality,
which is categorized into three levels (A, B and C) according to the
extent of lymphadenectomy of intermediate and main lymph nodes
(Fig. 2).
Prior to bowel resection, the distance from the closest tumor edge
is measured in the natural state, and the points at 5, 10, 15 and
20 cm from the proximal and distal edge of the tumor are respectively
marked on the bowel wall with a stitch (Fig. 3). This procedure
yields 11 pericolic segments (primary tumor area; 0 < distance from
the edge of the primary tumor (D) ≤ 5 cm; 5 < D ≤ 10 cm;
10 < D ≤ 15 cm; 15 < D ≤ 20 cm; and 20 cm < D), which are
used to categorize the location of pericolic lymph nodes and feeding
arteries.
Postoperative procedure (pathological process)
Photographs of resected surgical specimens. High-resolution digital
color photographs are taken on fresh specimens immediately after
resection, including anterior and posterior views adjacent to a met-
ric scale for calibration (Fig. 6). All photographs are submitted to
the University of Leeds where morphometric analysis and surgical
specimen grading of the dissection plane based on the presence and
extent of any identifiable mesocolic defects will be made by one of
the authors (N.W.) according to a method previously reported (6, 7).
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Figure 5. Groupings of retrieved lymph nodes in the T-REX study. Retrieved lymph nodes from the resected specimens were classified into pericolic, intermediate
and main lymph nodes. The T-REX study provides subgroups of pericolic lymph nodes according to the pericolic segments determined by intraoperative markings
at 5 cm intervals.
Evaluation of the anatomical location of feeding arteries (Fig. 3). The
anatomical location of the primary feeding artery (a branch of the
superior or inferior mesenteric artery located closest to the primary
tumor) and the secondary feeding artery (artery arcade next to the
primary feeding artery) are evaluated on either fresh surgical spec-
imens or formalin-fixed specimens, depending on the pathological
practice adopted in individual institutions. Similar to the location
of the feeding arteries, the bowel segment that these feeding arteries
flow into is recorded using the abovementioned method of bowel
segmentation with intraoperative markings.
Grouping of the retrieved lymph nodes (Fig. 5). The timing of the
lymph node retrieval process (i.e. either before or after formalin fix-
ation) is recorded. Specimens retrieved as lymph nodes are examined
by routine pathological practice. In this study, tumor nodules with
no pathological evidence of lymph node structure are considered
as lymph node metastases, irrespective of their size and contour
morphology.
Lymph nodes retrieved from resected surgical specimens are
categorized as follows: pericolic lymph nodes (tumor area; 0 < D ≤
5 cm; 5 < D ≤ 10 cm; 10 < D ≤ 15 cm; 15 < D ≤ 20 cm; and
20 cm < D), intermediate lymph nodes (lymph nodes around the
primary feeding artery and lymph nodes around the other feeding
arteries) and main lymph nodes.
Analysis
All data, except prognostic data, will be fixed for analyses at the
end of June 2020. Primary analyses will be performed to elucidate
the distribution of metastatic lymph nodes. We will analyze not only
lymph node status in the resected specimen but also the status of
lymph node recurrence for the purpose of elucidating the actual
distribution of metastatic lymph node. Sub-group analyses for pri-
mary outcomes will be based on various essential clinicopathological
factors, including pT, types of feeding artery, tumor location and
populations. The results of these outcomes will be presented as
the frequency of metastasis and the percentage of accuracy with a
measure of precision (95% confidence intervals).
The T-REX study will also estimate prognostic outcomes accord-
ing to the bowel resection length and central radicality as a secondary
outcome. As another secondary outcome, this study will focus on the
morphometric data of resected specimens, as well as on the plane
of surgery evaluated by the quality of surgical specimens. Various
statistical methods, including the chi-squared test and t-test, will be
used to evaluate the differences. To analyze the survival durations,
the Kaplan–Meier survival curves and the log-rank test will be used.
Discussion
The oncological outcomes of colon cancer surgery are greatly
influenced by the quality of surgery, particularly with lymph node
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Table 1. Collaborating institutions in the T-REX study
Japan (from north to south)
1. Keiyukai Sapporo Hospital
2. Yamagata Prefectural Central Hospital
3. Tochigi Cancer Center
4. National Defense Medical College
5. Saitama Cancer Center
6. National Cancer Center Hospital East
7. Teikyo University Chiba Medical Center
8. National Cancer Center Central Hospital
9. Tokyo Medical and Dental University
10. Teikyo University School of Medicine
11. Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
12. Kyorin University School of Medicine
13. Tokyo Women’s Medical University
14. Kanagawa Cancer Center Hospital
15. Yokohama City University
16. Yokohama City University Medical Center
17. Saiseikai Yokohamashi Nanbu Hospital
18. Niigata Cancer Center
19. Shizuoka Cancer Center Hospital
20. Aichi Cancer Center Hospital
21. Fujita Health University
22. Mie University Graduate School of Medicine
23. Shiga University of Medical Science
24. Osaka International Cancer Institute
25. Wakayama Medical University
26. Kurume University School of Medicine
27. Takano Hospital
South Korea
1. Yonsei University
2. Asan Medical Center
Germany
1. University Hospital Erlangen
Russia
1. First Moscow State Medical University
Lithuania
1. Klaipeda University Hospital
2. National Cancer Institute
Taiwan
1. National Taiwan University Hospital
2. China Medical University Hospital
UK
1. Leeds Universitya
aProtocol development and evaluation of the photographs of resected surgical specimens.
dissection. The pericolic lymph nodes located along the bowel
and marginal artery are the most common site of metastasis
in colon cancer (8). Currently, there are no standardized cri-
teria for regional lymph nodes in the pericolic region, which
should be resected in routine practice because of the possi-
bility of harboring metastasis. For example, the tumor–node–
metastasis classification regards all pericolic lymph nodes as regional
lymph nodes, with no sub-classification based on their clinical
implications. The T-REX study is expected to identify the anatomical
distribution of metastatic pericolic lymph nodes, particularly in
terms of their association with the location of the primary tumor
and feeding arteries, which determines regional pericolic lymph
nodes.
In Western countries, the bowel resection length is generally
thought to depend on the area of the arterial supply to the colon
(9). In addition, the vascular arcade next to the primary feeding
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Table 2. Clinical and pathological data collected from the T-REX study
Clinical and pathological data
Patient characteristics
− Age and sex
− Height and body weight
− Tumor location
Surgery-related factors
− Year and month of surgery
− Operation type (open/laparoscopic)
− Intraoperative marking method (under direct vision/laparoscopic)
− Length of the bowel resected (proximal/distal to the tumor)
− Level of central radicality (Fig. 2)
− Operation time and blood loss
− Morbidity (Clavien–Dindo grade) and 30-day mortality
Feeding artery information
− Name of first and second feeding arteries
− Location of first and second feeding arteries (distal/proximal/within the tumor area)
− Distance from the primary tumor (cm) (Fig. 3)
− Pattern of feeding artery distribution (Fig. 4)
Pathological information
− Timing of lymph node retrieval (before fixation/after fixation)
− pT stage
− Tumor grade
− Residual tumor (R0/R1)
− Circumferential resection margin
− Number of lymph nodes retrieved and involved
(a) Pericolic lymph nodes according to the 5 cm interval (Fig. 5)
(b) Intermediate lymph nodes (around first feeding artery/around other feeding arteries)
(c) Main lymph nodes
Postoperative treatment
− Adjuvant chemotherapy
Prognostic outcomes
− Year and month of final follow-up
− Prognostic outcomes and cause of death
− Year and month of recurrence
− Recurrence site
(remnant mesenteric lymph nodes/anastomosis/liver/lung/peritoneum/non-mesenteric
lymph nodes/other)
Other
Photographs of resected specimen (Fig. 6)
artery is routinely resected (2). Consequently, wide bowel resection is
conventionally applied in routine practice (2, 3). In Japan, in contrast,
bowel resection 10 cm from the tumor edge (the 10 cm rule) has
long been used in routine clinical practice on the assumption that the
10 cm rule ensures that no regional pericolic lymph nodes remain
(10, 11).
Recently, in Japan, the definition of pericolic regional lymph
nodes was revised in the Japanese Classification of Colorectal Carci-
noma (second English edition, 2009) published by the JSCCR (4). In
this definition, the distribution of the feeding artery is classified into
four patterns (Fig. 4), and in addition to an anatomical landmark
of 10 cm from the primary tumor, another landmark (5 cm from
the feeding artery) was adopted to define regional lymph nodes
depending on feeding artery distribution (the feeding artery-oriented
rule) (4).
Currently, we have no robust scientific evidence to support
the appropriateness of the extent of bowel resection based on
the Western-type wide resection, the 10 cm rule or the feeding
artery-oriented rule. With both CME with central vascular ligation
and Japanese D3 dissection, which have reported good surgical
outcomes (1, 6, 12), radical central lymph node dissection, including
removal of the main nodes (lymph nodes located around the superior
mesenteric artery/vein or the inferior mesenteric artery/vein), is
applied. However, the questions of whether the resection of main
nodes should be included in central lymph node dissection and
who should receive this kind of extended operation, if it should
be included, have not been solved.
It is well recognized that among populations, there are great
differences in physical characteristics, including body size and body
habitus. We should consider the possible differences in the anatom-
ical structures in the bowel, including the anatomical distribution
of feeding arteries to the colon, which can affect the distribution of
metastatic lymph nodes and the optimal anatomical area for lym-
phadenectomy (2). The T-REX study is expected to elucidate whether
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Figure 6. Photography protocol for of colon cancer specimens. General principles. (1) Photographs should be taken with a high-resolution digital camera; (2) the
camera should be mounted on a fixed stand to minimize movement artifacts; (3) images should not contain any direct patient identifiers but should be identified
by the unique study number and preferably a second indirect identifier; (4) all images must include a metric scale to allow calibration when using image analysis
software and (5) a white background is ideal, although any plain color is acceptable. Whole-specimen photographs: (1) ideally, the whole specimen should be
photographed before it is opened; (2) the mesentery should be laid out flat but not under tension; (3) the site of the tumor and the site of the vascular ties
must be clearly visible on the photographs; (4) the whole specimen should be visible in the image; (5) photographs should be taken from both the front and
the back of the specimen; (6) ideally, the distal and proximal aspects should be labeled (mainly for left-sided and wedge excisions where orientation may be
difficult); (7) photographs should be taken directly above the specimen to reduce distortion artifact and (8) additional close-up pictures if any mesocolic defects
or perforations exist.
an international standard for regional lymph nodes is possible in
colon cancer.
In conclusion, the T-REX study aims to clarify the metastatic
lymph node distribution in colon cancer. This study would enable
establishment of standardized criteria for the definite area of regional
lymph nodes in colon cancer, thereby providing reliable evidence
about the optimal length of bowel resection and the extent of central
lymphadenectomy in colon cancer surgery.
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